- Home
- VMAR vs CPHI Comparison
VMAR vs CPHI Comparison
Compare VMAR & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- CPHI
- Stock Information
- Founded
- VMAR 1995
- CPHI N/A
- Country
- VMAR Canada
- CPHI China
- Employees
- VMAR N/A
- CPHI N/A
- Industry
- VMAR Marine Transportation
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- CPHI Health Care
- Exchange
- VMAR Nasdaq
- CPHI Nasdaq
- Market Cap
- VMAR 4.5M
- CPHI 4.6M
- IPO Year
- VMAR 2020
- CPHI N/A
- Fundamental
- Price
- VMAR $1.37
- CPHI $1.36
- Analyst Decision
- VMAR
- CPHI
- Analyst Count
- VMAR 0
- CPHI 0
- Target Price
- VMAR N/A
- CPHI N/A
- AVG Volume (30 Days)
- VMAR 1.5M
- CPHI 75.8K
- Earning Date
- VMAR 07-11-2025
- CPHI 08-14-2025
- Dividend Yield
- VMAR N/A
- CPHI N/A
- EPS Growth
- VMAR N/A
- CPHI N/A
- EPS
- VMAR N/A
- CPHI N/A
- Revenue
- VMAR $1,128,568.00
- CPHI $4,396,201.00
- Revenue This Year
- VMAR N/A
- CPHI N/A
- Revenue Next Year
- VMAR $264.29
- CPHI N/A
- P/E Ratio
- VMAR N/A
- CPHI N/A
- Revenue Growth
- VMAR N/A
- CPHI N/A
- 52 Week Low
- VMAR $1.30
- CPHI $1.20
- 52 Week High
- VMAR $286.19
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- VMAR 14.46
- CPHI 40.51
- Support Level
- VMAR $1.46
- CPHI $1.38
- Resistance Level
- VMAR $1.64
- CPHI $1.53
- Average True Range (ATR)
- VMAR 0.25
- CPHI 0.08
- MACD
- VMAR -0.04
- CPHI 0.01
- Stochastic Oscillator
- VMAR 1.81
- CPHI 36.84
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.